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Accepted 13 September 2011AbstractObjective: To study the possible non-genomic effect of selective estrogen receptor modulators on human dermal fibroblasts (HDF).
Materials and Methods: WS1 cells were used to test the effect of raloxifene. The mRNA expressions of estrogen receptor (ER) a and b and G
protein-coupled ER 1(GRP30) were examined by reverse transcription polymerase chain reaction. Apoptosis was identified by TUNEL assay
and FACS analysis. MAPK and PI3 K/Akt pathways were determined by immunoblotting analysis.
Results: Neither ERa nor ERb, but GPR30 was detected in WS1 cells. Raloxifene increased apoptosis, which was blocked by pertussis toxin, an
inhibitor of G protein, or by LY294002. Phosphorylated p38 MAPK and Akt were also increased after raloxifene treatment.
Conclusion: SERMs could induce apoptosis of HDF through G protein and PI3 K/Akt signaling, which may help understand the role of SERMs
on the skin.
Copyright  2011, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Keywords: Apoptosis; Estrogen; Human dermal fibroblasts; Non-genomic; Selective estrogen receptor modulatorIntroduction
A number of studies have shown the important roles of
estrogen on the skin, based on the changes that are seen in
postmenopausal women [1]. However, despite the knowledge
that estrogens have such important effects on skin and
estrogen receptors (ERs) have been detected in the skin, the
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doi:10.1016/j.tjog.2011.10.013action are still poorly understood [2]. In addition, there is very
limited data available addressing the effects of selective
estrogen receptor modulators (SERMs) on skin [2]. Due to the
potential risk of the use of estrogen after menopausal status,
SERMs have been considered as a possible alternative in
postmenopausal women [3e6]. Classically, estrogen action is
mediated through ER dimers, including ERa and ERb [7, 8].
However, non-genomic or ER-independent estrogen action
is shown. Therefore, it is reasonable to suppose that these
molecules, such as SERMs, might act on the skin through
a non-genomic effect. An orphan receptor G protein-coupled
estrogen receptor 1 (GPR30), which belongs to one of
several guanine nucleotide-binding protein (G-protein)-
coupled receptors [9, 10], is also reported to be one of the
estrogen-mediated non-genomic effects.
The aim of this study was to determine the possible non-
genomic effect of estrogen, and SERMs on skin; therefore,cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
475K.-H. Tsui et al. / Taiwanese Journal of Obstetrics & Gynecology 50 (2011) 474e478WS1 cells, human dermal fibroblasts (HDFs) without
expression of both ERa and ERb, were tested.
Materials and methods (Supplementary materials and
methods)ReagentsReagents for the treatment of HDF were prepared as
follows: raloxifene (RAL), G protein inhibitor pertussis toxin
(from Sigma, St Louis, MO, USA), PI3 K inhibitor LY294002,
ERK inhibitors PD98059, and p38 MAPK inhibitor SB203580
(from Calbiochem; San Diego, CA, USA) were dissolved in
dimethylsulfoxide (DMSO; Sigma).Cell cultureThe normal human fetal skin fibroblast cell line, WS1, was
isolated from the midscapular skin of a 12-week-old African-
American female embryo; this line has a doubling potential
of 67. The cells were cultured in minimum essential medium
(MEM; Gibco, Grand Island, NY, USA) supplemented with
10% fetal bovine serum (FBS; Hyclone, Logan, UT, USA),
2 mM L-glutamine (Sigma), 100 units/mL penicillin (Sigma),
and 100 mg/mL streptomycin (Sigma). Cells were maintained
in 100-mm tissue culture dishes in a humidified chamber at 5%
CO2 and 37
C, and subcultured every 2 to 3 days by trypsin-
EDTA (Gibco, Grand Island, NY, USA). For all subsequent
experiments, WS1 cells were seeded in MEM Alpha medium
without phenol red (a-MEM without phenol red; Gibco). After
18 hours of incubation, the medium was replaced and the cells
were subjected to various drug treatments.WST1 assayWST1 cell proliferation reagent (Roche, Mannheim, Ger-
many)measures themetabolic activity of viable cells. Cellswere
seeded in 96-well plates at 5 103 cells/100 mL/well. Following
18 hours of incubation, various drugs were added to the cell
culture. After the indicated time, the supernatants were dis-
carded and the cells werewashedwith phosphate buffered saline
(PBS). Then, WST1 was added to each well at a 1:20 dilution,
and the cells were incubated at 37C for a further 2 hours. The
supernatants were quantified spectrophotometrically at 450 nm,
with a reference wavelength at 640 nm. Data were presented as
the percentage of survival relative to that in a vehicle-treated
control culture. All WST1 assays were performed in duplicate.RNA isolation and RT-PCRTotal RNA was collected with the RNeasy kit (Qiagen,
Milan, Italy) as described by the manufacturer. For reverse
transcription polymerase chain reaction (RT-PCR) studies,
first-strand cDNA was synthesized from 1e5 mg of total RNA
with an oligo(dT) primer and Super Script II reverse tran-
scriptase (Invitrogen, Life Technologies, Inc., Carlsbad, CA,
USA). Primers for human ERa, ERb, GPR30, and GAPDHgenes are as follows (50 to 30): ERa, forward, CTA CTG CAT
CAG ATC CAA GG; reverse, GTC ATT GGT ACT GGC
CAA TCT; ERb, forward, TGG TCA GGG ACA TCA TCA
TGG; reverse, TCA AAG AGG GAT GCT CAC TTC TG;
GPR30, forward, GGC TTT GTG GGC AAC ATC; reverse,
CGG AAA GAC TGC TTG CAG G; GADPH, forward, ATT
GTT GCC ATC AAT GAC CC; reverse, AGT AGA GGC
AGG GAT GAT GT. The conditions used for amplification
were as follows: 94C for 30 seconds followed by 52C for 1
minute and 72C for 30 seconds in a 25-mL reaction buffer
containing cDNA generated from 1 mL of cDNA, 0.2 mM of
each dNTP, 0.2 mM of each primer, and 2.5 units of Taq
polymerase. Detection of the amount of PCR product after 35
cycles was performed after electrophoresis on 1.5% agarose
gels and ethidium bromide staining.Detection of apoptosis by TUNEL analysisApoptosis of the single cell is detected by fluorescent labeling
of DNA strand breaks (a hallmark of apoptosis). Cells were
plated in 35-mm culture dishes at 5 105 per dish and cultured
overnight, followed by the administration of test reagents. After
an indicated interval of drug treatments, the supernatant was
discarded and the cells were collected by trypsinization. The
cells were washed twice with PBS and fixed by incubating in 4%
paraformaldehyde at room temperature for 1 hour. After another
PBS wash, the cells were permeabilized by resuspension in
0.1% Triton X-100 (Sigma) in 0.1% sodium citrate (Sigma) on
ice for 2minutes, followed by a PBSwash. Then a 50 ml TUNEL
reaction mixture (In Situ Cell Death Detection Kit; Roche),
which contained terminal deoxynucleotidyl transferase and
fluorescein-labeled nucleotides, was added and the cells were
incubated at 37C for 1 hour in the dark. After a further PBS
wash, the cells were subjected to fluorescence-activated cell
scanning analysis (FACS; BD, Palo Alto, CA, USA) with exci-
tation at 488 nm and emission at 525e550 nm.FACS analysis for activated caspases in apoptotic cellsCaspACE FITC-VAD-FMK in situ marker (Promega,
Madison, WI, USA) is a fluoroisothiocyanate (FITC) conjugate
of the cell-permeable caspase inhibitor VAD-FMK. This
structure allows delivery of the inhibitor into the cell, where it
binds to activated caspases, serving as an in situ marker for
apoptosis. Cells cultured in 35-mm dishes were treated with
various drugs. At the end of cell culture, the supernatant was
removed and the cells were detached by trypsin-EDTA. After
two consecutive PBS washes, the cells were stained with 10 mM
CaspACE FITC-VAD-FMK In Situ Marker, followed by incu-
bation at room temperature in the dark for 20 minutes. Cells
were then washed with PBS and subjected to FACS analysis
with excitation at 488 nm and emission at 525550 nm.Immunoblotting assayImmunoblotting assays were performed to measure the
synthesis of procollagen type I and to detect the activation of
Fig. 1. (A) Detection of mRNA expression of ERa, ERb, and GPR30 in WS1
cells by RT-PCR; (B) WS1 cells were pretreated with or without 0.25 mg/mL
pertussis toxin (PTX) 1 hour before the addition of 10 mM RAL or the cor-
responding vehicle, followed by culture for 24 hours. Subsequently, TUNEL
staining and FACS analysis were performed.
Fig. 2. (A) Detection of apoptosis by TUNEL staining; (B) measurement of
activated caspases by VAD-FMK staining in WS1 cells treated with RAL.
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5 105 per dish and cultured overnight, followed by the
addition of various drugs. The treatments were terminated
after indicated intervals by aspirating supernatants and
washing the dishes with PBS. The cells were lysed by keeping
the dish on ice for 5 minutes with 70 mL of lysis buffer
(20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM
b-glycerophosphate, 1 mM Na3VO4, 1 mg/mL leupeptin, and
1 mM phenylmethylsulfonyl fluoride). The lysed cells were
scraped off the dish, transferred to microcentrifuge tubes, and
vortexed for 10 seconds. The cell lysates were then centri-
fuged at 18000 g, 4C for 10 minutes to remove insoluble
material, and the protein concentration of each sample was
measured. Approximately 1550 mg of supernatant protein
from each sample was fractionated by 10% SDS-polyacrylamide
gel electrophoresis. After electrophoresis, the fractionated
cellular proteins were transferred to polyvinylidene fluoride
membranes (PVDF; NEN Life Science Products, Inc., Boston,
MA, USA). For immunoblotting, the membranes were blocked
with 5% non-fat milk in TBST [25 mM Tris, pH 7.5, 150 mM
NaCl, 0.1% (v/v) Tween 20] and incubated overnight at
4C with one of the following primary antibodies: rabbit
anti-human phospho-ERK antibody, rabbit anti-human ERKantibody, rabbit anti-human phospho-JNK antibody, rabbit
anti-human JNK antibody, rabbit anti-human phospho-p38
antibody, rabbit anti-human p38 antibody (Cell Signaling
Technology, Beverly, MA, USA), goat anti-human procollagen
type I antibodies (Santa Cruz Technology, Santa Cruz, CA,
USA), or mouse anti-human actin antibody (Upstate Tech-
nology, Charlottesville, VA, USA). The PVDF membranes
were then extensively washed with TBST and incubated for 60
minutes at room temperature with corresponding secondary
antibodies: goat anti-rabbit antibody, donkey anti-goat anti-
body (Santa Cruz Technology), or goat anti-mouse antibody
(Upstate Technology). After extensive washing with TBST, the
immune complexes were detected by chemiluminescence
using the Western Blotting analysis system (NEN Life Science
Products, Inc., Boston, MA, USA).Statistical analysisData of the WST1 assays were analyzed by analysis of
variance (ANOVA), followed by Fisher’s post-hoc least
significant difference (LSD) test. A p value <0.05 was
Fig. 3. Effects of RAL on: (A) phospho-ERK1 and ERK2; (B) phospho-p38;
and (C) phospho-Akt activation in WS1 cells.
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formed using the SAS program (SAS Institute Inc., Cary. NC,
USA).
ResultsConfirmation of absent expression of ERa and ERb but
presence of GPR30 on WS1 cellsWe used MCF7 breast cancer and DU145 prostate cancer
cells for positive controls of ERa and ERb. There was neither
ERa nor ERb mRNA expression in the WS1 cells. By
contrast, GPR30 mRNA was detected in the WS1 cells
(Fig. 1A). Following the above results, we supposed that the
apoptosis of WS1 induced by raloxifene may be mediated by
GPR30. To test this hypothesis, we added 0.25 mm/mL
pertussis toxin (PTX), an inhibitor of G protein signaling, 1
hour before the administration of RAL, followed by TUNEL
staining and flow cytometry. The RAL-induced apoptosis was
significantly inhibited by pre-treatment with PTX (Fig. 1B).Fig. 4. Effects of p38 MAPK, ERK and PI3 K inhibitors on RAL-induced apopt
inhibitor); (B) 20 mM PD98059 (an ERK inhibitor); (C) 50 mM Z-VAD (a caspas
administration of 10 mM RAL. Cell culture was continued for 24 hours. Then, TUApoptosis of WS1 was increased by RAL treatmentWe used TUNEL staining and FACS analysis for detection
of DNA strand breaks to assess whether WS1 cell death
caused by RAL was due to apoptosis. After treatment with
110 mM RAL for 24 hours, all cells were collected, stained,
and analyzed by flow cytometry. We found that RAL could
increase the percentage of TUNEL-positive cells in a dose-
dependent manner (Fig. 2A). On the other hand, RAL was
found to increase the level of fluorescent staining with acti-
vated caspases only at 10 mM (Fig. 2B).Apoptosis was mediated by ERK, MAPK and Akt
pathways in WS1 cells treated with RALTo study which signal transduction pathway (ERK, MAPK
or Akt) was involved in RAL-induced apoptosis, WS1 cells
were treated with 10 mM RAL, followed by protein extraction
for immunoblotting analysis. The level of phosphorylated
ERK (phospho-ERK1 and ERK2) was not increased upon
exposure to RAL (Fig. 3A). Phosphorylated p38 MAPK
(phosphor-p38) significantly increased under RAL treatment
after 4 hours (Fig. 3B). Akt, the downstream target of PI3 K,
was activated at 30 minutes after stimulation with RAL
(Fig. 3C). Then, we used an inhibitor (SB203580, PD98059,
LY294002) to inhibit the above signal transduction pathway.
Inhibition of PI3 K/Akt with LY294002 successfully rescued
cells from RAL-induced apoptosis (Fig. 4).
Discussion
Deterioration of the skin with age in women may result
from many factors, including genetic and environmental
factors [11]. Among these, estrogen might be one of theosis. WS1 cells were pre-treated with: (A) 20 mM SB203580 (a p38 MAPK
e inhibitor); and (D) 20 mM LY294002 (a PI3 K inhibitor) 1 hour before the
NEL staining was performed and detected by FACS analysis.
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ciated with a variety of skin changes in women, and the
expression of cutaneous ERs is also decreased after the
menopause [12]. However, in addition to estrogen, SERMs
were also reported to be capable of interaction with ERs,
though with a different affinity to the subtypes of ERs [13].
However, a recent study showed the possibility of a non-
genomic effect of estrogen or SERMs, including identifica-
tion of a rapid non-genomic effect of E2 on intracellular Ca2þ
([Ca2þ]i) signaling in the eccrine sweat gland epithelial cell
line NCL-SG3 [14]. To study the possibility of the non-
genomic effect of SERMs on skin tissue, an ER-negative
HDF cell line, WS1, was used to test our hypothesis.
In this study, SERMs showed a strong inhibition of the cell
growth of these ER-negative cells. TUNEL staining and FACS
analysis showed apoptosis of these cells was significant at high
concentrations (above 1 mM) with the use of RAL, suggesting
that the toxic effect of the SERMs might not be mediated
through the classical ER pathway.
In clarifying the above hypothesis, RT-PCR analysis veri-
fied that WS1 cells were positive for GPR30 mRNA expres-
sion [9, 10]. We used pertussis toxin (PTX), which could
disrupt G protein signaling, in the management of WS1 cells
before the administration of SERMs, and found that the
SERM-inducing apoptosis of WS1 cells could be blocked,
suggesting that the GPR pathway was involved in the
apoptosis of WS1 cells after SERM treatment. Furthermore,
we identified the p38 MAPK and PI3 K/Akt pathway in WS1
cells treated with RAL and found activation of the p38 MAPK
and PI3 K/Akt pathway, suggesting that this pathway might
also involve the apoptosis of WS1 cells. To confirm this
hypothesis, we used an inhibitor, the LY294002 of PI3 K/Akt
pathway, in the management of WS1 cells treated with RAL,
and successfully rescued these cells from RAL-induced
apoptosis. The results demonstrated that RAL could induce
apoptosis in HDF via G protein signaling and the PI3 K/Akt
pathway. In an updated study, G protein-coupled estrogenFig. 5. A proposed model of signaling pathways of RLX-induced apoptosis in
HDF. High-dose RLX could bind to membrane-bound GPR30 and then acti-
vate PI3 K/Akt to induce apoptosis in HDF, which belongs to the non-genomic
pathway.receptor (GPER) expressed in the cardiovascular system, has
recently been identified. Endogenous human 17b-estradiol,
SERMs including tamoxifen and raloxifene, and selective
estrogen receptor downregulators, such as ICI182780, are all
agonists of GPER, which has been implicated in the regulation
of vasomotor tone and protection from myocardial ischemia/
reperfusion injury [15]. The possible signal transduction
pathway of RAL on WS1 cells is depicted in Fig. 5.Conclusions
Our results established that RAL could induce apoptosis via
the G protein and PI3 K/Akt pathways in WS1 cells.References
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